RareSum
PrivateLast Round
Pre Seed
Mar 1, 2025
Total Funding Raised
$150,000
Company Overview
RareSum operates in Healthcare & Life Sciences and is based in Turkey. Its latest recorded funding round was a Pre Seed round in March 2025.
RareSum is a health-tech company that provides an AI-powered clinical decision support platform to assist physicians in the early diagnosis of rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Precision Medicine, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RareSum Comparables
Compare RareSum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenEngine | 81% | |
| Volv Global | 80% | |
| ThinkGenetic, Inc. | 78% |
For institutional investors. Book with your work email.
RareSum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 1, 2025 | ||||
| Seed | Feb 19, 2025 | ||||
| Accelerator | Oct 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RareSum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sabancı ARF | Accelerator, Pre Seed |
| Techventure VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2025
Raised a Seed round with Techventure VC participating.
- Oct 1, 2024
$30K round from Sabancı ARF
For institutional investors. Book with your work email.
RareSum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RareSum's valuation, stock price, and market status.
Is RareSum a public or private company?
RareSum is a private company.
What is the current stock price of RareSum?
RareSum is a private company, so its shares have no public market price. Caplight tracks RareSum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RareSum worth (valuation)?
Valuation information for RareSum is not publicly available.
Can I buy RareSum stock?
RareSum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RareSum's last funding round?
RareSum's most recent funding round was Pre Seed on March 1, 2025.
Who are the main investors in RareSum?
Key investors in RareSum include Sabancı ARF.
Will RareSum IPO soon?
No public IPO plans have been announced for RareSum.
How can I track RareSum secondary market activity?
Caplight tracks bids, offers, and trades in RareSum's shares on secondary markets.